Siemens Healthineers cut its full-year outlook for revenue growth on Friday, citing a weak performance in its diagnostics segment, but raised its guidance for adjusted earnings due to U.S. tariff refunds. The German supplier of medical equipment said it now expects revenue for the year ending in September to grow by between 3.5% and 4.0% on a comparable basis compared with the year before. It had previously forecast comparable revenue growth of 4.5% to 5%.

However, the benefit of tariff refunds prompted Siemens Healthineers to raise its outlook for full-year adjusted basic earnings per share to between 2.35 and 2.45 euros ($2.71-$2.82), compared with a previous range between 2.20 and 2.30 euros.

For the fiscal third quarter ended June 30, a decline in diagnostics revenue also dragged down the group's top-line, while tariff refunds flattered its bottom line. The mixed results reflect ongoing challenges in the diagnostics business offset by one-time tariff benefits.